Wen-I Yeh, Ph.D.

Scientist
Fate Therapeutics

Poster(s):

• Tu77 - Selective CD226 Knockout on Regulatory T Cells Reduces Diabetes in Female Non-obese Diabetic Mice
  Tuesday, June 21, 2022

  6:15 PM – 7:45 PM PT